Article
Two mild phenotype molybdenum cofactor deficiency patients with novel MOCS2 mutation and immunological treatment after COVID-19 infection.
BMC neurology - 23 Feb 2026
Shi Zhen, Zhu Jun, Cao Binbin, Tian Yang, Yu Jie, Hou Chi, Zhu Haixia, Wang Xiuying, Peng Bingwei, Zhang Yani, Zheng Kelu, Li Xiaojing, Gao Yuanyuan
Abstract excerpt
BACKGROUND: Molybdenum cofactor deficiency type B (MoCD-B) is a rare autosomal recessive metabolic disorder caused by mutations in MOCS2. Patients with mild phenotypes may experience infection-related neurological deterioration followed by partial spontaneous recovery. This study presents the first reported cases of acute encephalopathy triggered by SARS-CoV-2 infection in patients with mild MoCD-B and provides...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.